… early Alzheimer's disease (AD) and mild cognitive impairment (MCI), plasma biomarkers are
… We review the current state of knowledge on plasma biomarkers for MCI and AD, including …

… plasma biomarkers and basic demographics best predicted change in cognition (Pre-Alzheimer’…
In a simulated clinical trial, a screening algorithm combining all three plasma biomarkers …

… have created a need for biomarkers that reflect core elements of the disease process. Here,
… ) and plasma biomarkers for AD. We focus on established biomarkers (biomarkers evaluated …

… This study investigated the diagnostic and disease-monitoring potential of plasma biomarkers
in mild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia and cognitively …

… co-pathology and different types of amyloid pathology influence these plasma biomarkers.
Finally, we examine the relationship between plasma biomarkers and cognitive change. …

… To address this unmet need, plasma biomarker tests are being developed for use in Alzheimer's
disease (AD). Plasma biomarker tests span various stages of development, including in …

… In summary, using a 2-DGE proteomics based approach in Alzheimer's disease plasma we
… between Alzheimer's disease cases, normal controls and other neurodegenerative diseases. …

Introduction Plasma biomarkers for Alzheimer's disease (AD) diagnosis/stratification are a “Holy
Grail” of AD research and intensively sought; however, there are no well-established …

… plasma biomarkers … biomarkers in preclinical AD and assess if they have value to assist
with the identification of Aβ+ CU for recruitment into clinical trials. We observed higher plasma …

… if it can be proven to be a reliable predictor of Alzheimer's disease. The results for plasma
biomarkers have been conflicting, however; increasing evidence shows that plasma Aβ may …